Search results
CEO, Pharmaceutical Segment WEITZMAN DEBORAH sold 36,642 shares of Cardinal Health, Inc. [CAH] –...
Knox Daily· 19 hours agoAs published in their initiating research note from Leerink Partners on February 26, 2024, Cardinal Health, Inc. [CAH] has been an Outperform and the price target has been ...
FY2024 EPS Estimates for Cardinal Health, Inc. (NYSE:CAH) Lifted by Zacks Research
ETF DAILY NEWS· 2 days agoCardinal Health, Inc. (NYSE:CAH – Free Report) – Research analysts at Zacks Research boosted their FY2024 earnings per share (EPS) estimates for shares of Cardinal Health ...
Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Securian Asset Management Inc.
ETF DAILY NEWS· 5 days agoSecurian Asset Management Inc. lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 14.4% in the 4th quarter, according to the company in its ...
What You Didn’t Know About Cardinal Health, Inc.
Stocks Register· 3 days agoCardinal Health, Inc. (NYSE:CAH) traded at $96.01 at close of the session on Tuesday, May 21, made a downward move of -2.49% on its previous day’s price. Looking at the stock ...
Kentucky Retirement Systems Insurance Trust Fund Sells 363 Shares of Cardinal Health, Inc. (NYSE:CAH...
ETF DAILY NEWS· 5 days agoKentucky Retirement Systems Insurance Trust Fund decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 4.0% during the fourth quarter, according ...
Baird raises Crinetics shares target citing promising drug results By Investing.com
Investing.com· 2 days agoThe adjustment follows the early release of abstracts related to the company's drug atumelnant,...
HC Wainwright Analysts Cut Earnings Estimates for Spruce Biosciences, Inc. (NASDAQ:SPRB)
ETF DAILY NEWS· 7 days agoSpruce Biosciences, Inc. (NASDAQ:SPRB – Free Report) – Equities researchers at HC Wainwright cut their Q2 2024 EPS estimates for Spruce Biosciences in a research note issued to investors on ...
Capsule look at the District 2 baseball playoffs
The Citizens' Voice· 5 days agoCLASS 6A
Earnings call: Autolus Therapeutics Reports Progress and Financials for Q1 2024 By Investing.com
Investing.com· 6 days agoIn a recent earnings call, Autolus Therapeutics (NASDAQ:AUTL), a biopharmaceutical company...
Pixel 8a falls behind Pixel 8 and Galaxy S24 in PhoneArena Camera Score, but beats mid-range...
PhoneArena· 7 days agoThe Google Pixel 8a is the latest and arguably one of the best budget phones in the market. The...
